It is important to state what a "pharmaceutical
trademark" is. When I use the term, I do not intend to mean or
create a new legal type of trademark. Nor do I refer directly to
class 5 of the Nice Classification since it covers more than
pharmaceutical products, such as "diapers for babies". I
use the term only for academic purposes, to identify trademarks
where protection is given to drugs and medications and where the
legal approach and solutions may be distinct from those of other
products.
Africa is a continent of big opportunities, especially for
pharmaceutical companies. According to the latest statistical data,
the market for the pharmaceutical industry in Africa will be worth
about €60 billion ($75 billion) by 2020. In this sense, a big
investment in protecting pharmaceutical trademarks in Africa is
predicted, and Angola is not an exception in this matter.
